Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5Z77
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,508
Award facts
- Contract value 100% obligated
- $29,507.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $29,507.94 delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 2.5 mg/0.5 mL pens on January 26, 2026, with an ultimate completion date of January 27, 2026. This non-set-aside, firm fixed-price contract was awarded competitively and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award is a child delivery order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 31, 2031, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
This delivery order represents a routine pharmaceutical procurement within DLA's medical supply chain operations, which support military treatment facilities, the Defense Health Agency, and other federal healthcare systems. AmerisourceBergen's extensive pharmaceutical distribution capabilities and established relationship with DLA through its primary IDC position the company as a critical vendor for federal medical procurement. The contract reflects the company's demonstrated ability to deliver specialty medications across multiple therapeutic domains on a firm fixed-price basis, including diabetes treatments such as Zepbound, which is indicated for weight management in eligible patients.
Quick answers
Who was awarded contract SPE2DR26F5Z77?
SPE2DR26F5Z77 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26F5Z77 worth?
The government has obligated $29,508 on SPE2DR26F5Z77.
Is contract SPE2DR26F5Z77 an order under another contract?
Yes. SPE2DR26F5Z77 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F5Z77 competed?
The extent of competition for SPE2DR26F5Z77 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award